| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Mal |
|
2345732-89-8 |
詳細(xì)
|
| Cyclooctyne-O-amido-PEG4-VC-PAB-Gly-Gly-NH-O-CO-Exatecan |
化合物 CYCLOOCTYNE-O-AMIDO-PEG4-VC-PAB-GLY-GLY-NH-O-CO-EXATECAN |
2699066-62-9 |
詳細(xì)
|
| Glucocorticoid receptor agonist-3 Ala-Ala-Mal |
|
3014393-35-9 |
詳細(xì)
|
| N-(4-Methyl-3-((1-methyl-6-((1-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)amino)phenyl)-3-(trifluoromethyl)benzamide |
|
2251799-53-6 |
詳細(xì)
|
| E1231 |
E1231 |
1031195-19-3 |
詳細(xì)
|
| Methyltetrazine-PEG24-amine |
|
2353410-18-9 |
詳細(xì)
|
| NITD-688 |
化合物 NITD-688 |
2407227-31-8 |
詳細(xì)
|
| PROTAC ERα Degrader-1 |
|
2417369-94-7 |
詳細(xì)
|
| Gly-7-MAD-MDCPT |
化合物 GLY-7-MAD-MDCPT |
2378427-68-8 |
詳細(xì)
|
| Sulfo-Cyanine5.5 NHS ester;Sulfo-Cy5.5 NHS ester;Sulfo-Cyanine5.5 SE |
磺化CY5.5-NHS |
2419286-92-1 |
詳細(xì)
|
| Folate-PEG1-mal |
|
2743004-48-8 |
詳細(xì)
|
| Ilomastat |
伊洛馬司他 |
142880-36-2 |
詳細(xì)
|
| CETYL-PG HYDROXYETHYL PALMITAMIDE |
N-(3-十六烷氧基-2-羥基丙基)-N-(2-羥基乙基)十六烷酰胺 |
110483-07-3 |
詳細(xì)
|
| ABBV-CLS-7262 |
|
2945073-88-9 |
詳細(xì)
|
| TRAP1-IN-1 |
福爾馬林 |
3031102-94-7 |
詳細(xì)
|
| ATBTA-Eu3+ |
ATBTA-鈾[III] |
601494-52-4 |
詳細(xì)
|
| 2-((1-Hydroxy-4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-sulfonamido)naphthalen-2-yl)thio)acetic acid |
|
780822-36-8 |
詳細(xì)
|
| PAC |
PAC |
2158322-33-7 |
詳細(xì)
|
| Val-Cit-amide-Cbz-N(Me)-Maytansine |
化合物 VAL-CIT-AMIDE-CBZ-N(ME)-MAYTANSINE |
1628543-59-8 |
詳細(xì)
|
| 6-(Diethoxy-phosphorylamino)-hexyl]-phosphoramidic acid diethyl ester |
6-(二乙氧基磷酸化胺)-己基]-磷酰胺酸二乙酯 |
1446282-35-4 |
詳細(xì)
|
| BS2G Crosslinker |
BS2G交聯(lián)劑 |
881415-72-1 |
詳細(xì)
|
| LMP744/MJ-III65/NSC706744 hydrochloride |
LMP744; LMP-744; LMP 744; MJ-III-65; NSC-706744 |
308246-57-3 |
詳細(xì)
|
| ceramide E |
|
100403-07-3 |
詳細(xì)
|
| DIPQUO |
DIPQUO |
1269365-82-3 |
詳細(xì)
|
| Bis-(N,N-PEG4-NHS ester)-Cy5 |
|
2107273-48-1 |
詳細(xì)
|
| MCC-DM1 |
|
1100692-14-5 |
詳細(xì)
|
| 7-Hydroxymethyl-10,11-MDCPT |
|
428816-69-7 |
詳細(xì)
|
| diaplasinin |
DIAPLASININ |
481631-45-2 |
詳細(xì)
|
| PSMA-Val-Cit-PAB-MMAE |
化合物 PSMA-VAL-CIT-PAB-MMAE |
2748039-79-2 |
詳細(xì)
|
| VH032-PEG1-O-C1-COOH |
VH032-聚乙二醇-氧-乙酸 |
2172820-08-3 |
詳細(xì)
|
| IM-2 |
|
2813269-89-3 |
詳細(xì)
|
| Exatecan-methylacetamide-OH |
|
2594423-51-3 |
詳細(xì)
|
| PC5-VC-PAB-MMAE |
化合物 PC5-VC-PAB-MMAE |
2922216-98-4 |
詳細(xì)
|
| (Z)-2-(4-Oxo-5-((1-phenyl-3-(p-tolyl)-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-3-yl)ethane-1-sulfonic acid |
|
1146616-14-9 |
詳細(xì)
|
| Fmoc-Lys(5-FITC)-OH |
|
1095493-05-2 |
詳細(xì)
|
| vc-PABC-DM1 |
化合物 VC-PABC-DM1 |
1416792-90-9 |
詳細(xì)
|
| JAK-IN-27 |
化合物 JAK-IN-27 |
2673176-36-6 |
詳細(xì)
|
| PROTAC eDHFR Degrader-1 |
|
2849442-92-6 |
詳細(xì)
|
| AK-1690 |
|
2984505-88-4 |
詳細(xì)
|
| (R)-7,7'-bis((S)-4-benzyl-4,5-dihydrooxazol-2-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene |
(Ra,S,S)-Bn-Spir
oBOX |
890090-22-9 |
詳細(xì)
|
| Dolastatin 15 |
DOLASTATIN 15 |
123884-00-4 |
詳細(xì)
|
| TSPO ligand-2 |
化合物 CARBONIC ACID |
1160640-95-8 |
詳細(xì)
|
| Piclamilast |
吡拉米司特 |
144035-83-6 |
詳細(xì)
|
| CHM 1 |
2-(2-fluorophenyl)-6,7-methylenedioxy-2-4-quinolone hydrate, NSC 656158 |
154554-41-3 |
詳細(xì)
|
| Fmoc-MMAF-Ome |
(S)-2-((2R,3R)-3 - ((S)-1 - ((5S,8S,11S,12R)-11 - |
863971-38-4 |
詳細(xì)
|
| Mal-Sulfo-DBCO |
MAL-SULFO-DBCO |
2028281-86-7 |
詳細(xì)
|
| (Z)-2-(4-Oxo-5-((1-phenyl-3-(4-(piperidin-1-ylsulfonyl)phenyl)-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-3-yl)ethane-1-sulfonic acid |
|
1146616-18-3 |
詳細(xì)
|
| (+)-SJ733 |
化合物 T17313 |
1424799-20-1 |
詳細(xì)
|
| Isopropyldiphenylphosphine |
異丙基聯(lián)苯膦 |
6372-40-3 |
詳細(xì)
|
| Mal-PEG4-VA-SG3132 |
|
1342820-68-1 |
詳細(xì)
|
| NHS-SS-Ph |
化合物 NHS-SS-PH |
2750799-12-1 |
詳細(xì)
|
| PH-HG-005-5 |
化合物 PH-HG-005-5 |
2810895-93-1 |
詳細(xì)
|
| Pitavastatin |
匹伐他汀 |
147511-69-1 |
詳細(xì)
|
| TM5441 |
CS-2510 |
1190221-43-2 |
詳細(xì)
|
| SPB |
858128-57-1 |
858128-57-1 |
詳細(xì)
|
| MC-betaglucuronide-MMAE-1 |
MC-BETAGLUCURONIDE-MMAE-1 |
1703778-92-0 |
詳細(xì)
|
| Mal-EGGGG-PEG8-amide-bis(deoxyglucitol) |
化合物 MAL-EGGGG-PEG8-AMIDE-BIS(DEOXYGLUCITOL) |
2360920-01-8 |
詳細(xì)
|
| TLR7/8 agonist 4 hydroxy-PEG6-acid |
化合物 TLR7/8 AGONIST 4 HYDROXY-PEG6-ACID |
2388520-23-6 |
詳細(xì)
|
| Puromycin |
嘌呤霉素 |
53-79-2 |
詳細(xì)
|
| AD4 |
|
2918262-09-4 |
詳細(xì)
|
| Cot inhibitor-2 |
8-氯-4-[(3-氯-4-氟苯基)氨基]-6-[[[1-(1-乙基-4-哌啶)-1H-1,2,3-三唑-4-基]甲基]氨基]-3-喹啉甲腈 |
915363-56-3 |
詳細(xì)
|
| Ly93 |
Ly93 |
1883528-69-5 |
詳細(xì)
|
| (S)-7,7'-bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene |
|
940880-34-2 |
詳細(xì)
|
| Mal-PEG2-Val-Cit-PABA |
馬來(lái)酰亞胺-二聚乙二醇-VAL-CIT-PABA |
1662687-83-3 |
詳細(xì)
|
| GGFG-Eribulin |
化合物 GGFG-ERIBULIN |
2841688-66-0 |
詳細(xì)
|
| Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan |
化合物 MAL-PEG2-GLY-GLY-PHE-GLY-EXATECAN |
1599439-54-9 |
詳細(xì)
|
| Cbz-N-amido-PEG20-acid |
CBZ-NH-PEG12-CH2CH2COOH |
1334177-88-6 |
詳細(xì)
|
| Tomaymycin DM |
(S)-8-hydroxy-7-methoxy-2-methylene-2,3-dihydro-1H-benzo[e]-pyrrolo[1,2-a][1,4]diazepin-5(11aH)-one |
945490-09-5 |
詳細(xì)
|
| Sulfo-DMAC-SPP |
1-(4-((3-(Dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
663599-11-9 |
詳細(xì)
|
| 1-PalMitoyl-2-oleoyl-sn-glycerol-3-phosphocholine |
1-棕櫚酰-2-油酰-卵磷脂 |
70778-75-5 |
詳細(xì)
|
| TAM470 |
|
1802498-63-0 |
詳細(xì)
|
| ATX968/DHX9-IN-2 |
DHX9 抑制劑2 |
2973395-71-8 |
詳細(xì)
|
| Gly-Mal-GGFG-Deruxtecan 2-hydroxypropanamide |
化合物 GLY-MAL-GGFG-DERUXTECAN 2-HYDROXYPROPANAMIDE |
2750623-07-3 |
詳細(xì)
|
| Hygrolidin |
Hygrolidin |
83329-73-1 |
詳細(xì)
|
| PC DBCO-PEG4-NHS ester |
|
2055025-02-8 |
詳細(xì)
|
| KB-141 |
KB-141 |
219691-94-8 |
詳細(xì)
|
| RIPK1-IN-7 |
RIPK1-IN-7 |
2300982-44-7 |
詳細(xì)
|
| SNPB-sulfo-Me |
SNPB-sulfo-Me |
890409-86-6 |
詳細(xì)
|
| Mal-amido-(CH2COOH)2 |
MAL-AMIDO-(CH2COOH)2 |
207613-14-7 |
詳細(xì)
|
| dMCL1-2 |
dMCL1-2 |
2351218-88-5 |
詳細(xì)
|
| 4,7-Dichloro-2,9-diphenyl-1,10-phenanthroline |
4,7-二氯-2,9-二苯基-1,10-菲羅啉 |
1956367-14-8 |
詳細(xì)
|
| Oxazole,2,2''-[(1R)-2,2'',3,3''-tetrahydro-1,1''-spirobi[1H-indene]-7,7''-diyl]bis[4,5-dihydro-4-phenyl-,(4S,4''S)- |
(R)雙[(4S)-(苯基)惡唑-2-基)]-7,7,-2,2,3,3-四氫-1,1,6,6'-二醇 |
890090-21-8 |
詳細(xì)
|
| CL2E-SN38 |
化合物 CL2E-SN38 |
1639139-65-3 |
詳細(xì)
|
| Acalabrutinib Impurity 11 |
阿卡替尼雜質(zhì) 11 |
2490433-97-9 |
詳細(xì)
|
| DI-87 |
(R)-2-((1-(2-(4-METHOXY-3-(2-MORPHOLINOETHOXY)PHENYL)-5-METHYLTHIAZOL-4-YL)ETHYL)THIO)PYRIMIDINE-4,6-DIAMINE |
2107280-55-5 |
詳細(xì)
|
| Hemiasterlin |
哈米特林 |
157207-90-4 |
詳細(xì)
|
| 8-[(1S)-2-amino-1-methyl-ethyl]-N-methyl-quinoline-4-carboxamide;dihydrochloride |
(S)-8-(1-氨基丙-2-基)-N-甲基喹啉-4-甲酰胺二鹽酸鹽 |
1476076-41-1 |
詳細(xì)
|
| (Z)-2-(5-((3-(4-Methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)ethane-1-sulfonic acid |
|
956793-84-3 |
詳細(xì)
|
| CL 316243 disodium salt |
5-[(2R)-2-([(2R)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL]AMINO)PROPYL]-1,3-BENZODIOXOLE-2,2-DICARBOXYLATE DISODIUM |
151126-84-0 |
詳細(xì)
|
| MS9449 |
|
2772612-96-9 |
詳細(xì)
|
| Taprostene/CG-4203 |
他前列烯 |
108945-35-3 |
詳細(xì)
|
| ALG-055009 |
|
2542029-03-6 |
詳細(xì)
|
| RIPK1-IN-19 |
化合物 RIPK1-IN-19 |
2763831-43-0 |
詳細(xì)
|
| GGFG-amide-glycol-amide-Exatecan |
化合物 GGFG-AMIDE-GLYCOL-AMIDE-EXATECAN |
2866301-18-8 |
詳細(xì)
|
| MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT |
|
2378428-19-2 |
詳細(xì)
|
| MC-Gly-Gly-Phe-Gly-GABA-Exatecan |
|
1599439-52-7 |
詳細(xì)
|
| Ropidoxuridine |
1-(2-脫氧-beta-呋喃核糖基)-5-碘-2-嘧啶酮 |
93265-81-7 |
詳細(xì)
|
| PDS-MMAE |
化合物 PDS-MMAE |
1613113-44-2 |
詳細(xì)
|